Resources

National ADAP Monitoring Project Annual Report

2014 ADAP Formulary Database: User’s Guide
11/18/2014 | Source: NASTAD - 
The ADAP Formulary Database (Database) details AIDS Drug Assistance Programs’ (ADAPs’) coverage of medications, both individually and by drug class, including antiretroviral (ARV) treatments, “A1” Opportunistic Infections (A1 OI) medications, treatments for hepatitis B and C, substance use treatment medications as well as vaccines and various laboratory tests. It was created as part of NASTAD’s National ADAP Monitoring Project, a longstanding effort to document new developments and challenges facing ADAPs, assess key trends over time, and provide the latest available data on the status of ADAPs. The Database includes results from all 50 states as well as the District of

NASTAD National ADAP Monitoring Project Annual Report - February 2014
2/11/2014 | Source: NASTAD - 

2013 National ADAP Monitoring Project Annual Report (Full Report)
7/22/2013 | Source: NASTAD - 

2013 National ADAP Monitoring Project Annual Report - Module Two
4/2/2013 | Source: NASTAD - Module Two provides updated ADAP enrollment information and highlights ADAPs’ progress towards the implementation of health reform.

Slide Set: 2013 National ADAP Monitoring Project Annual Report - Module Two
4/2/2013 | Source: NASTAD - Module Two provides updated ADAP enrollment information and highlights ADAPs’ progress towards the implementation of health reform.

Press Release: 2013 National ADAP Monitoring Project Annual Report - Module Two
4/2/2013 | Source: NASTAD - 

2012 National ADAP Monitoring Project Annual Report - Full Report
8/24/2012 | Source: NASTAD - 
Module One includes detailed information related to ADAP budgets, client enrollment and utilization, client demographics, prescription distribution and payment methods, expenditures and prescriptions filled, insurance coordination, program eligibility, and program management and administration.
 
Module Two includes updated enrollment and utilization data and detailed information on ADAP coordination with Medicare Part D, ADAP coordination with Pre-existing Condition Insurance Plans (PCIPs) and ADAP coordination with the CMS Section 1115 Waiver process.
 
Module Three highlights hepatitis treatments covered by ADAPs.


Slide Set: 2012 National ADAP Monitoring Project Annual Report - Modules Two and Three
3/20/2012 | Source: NASTAD - This slide set includes updated enrollment and utilization data, detailed information on ADAP coordination with Medicare Part D, ADAP coordination with Pre-existing Condition Insurance Plans (PCIPs) and ADAP coordination with the CMS Section 1115 Waiver process, and highlights hepatitis treatments covered by ADAPs.

Press Release: 2012 National ADAP Monitoring Project Annual Report - Modules Two and Three
3/20/2012 | Source: NASTAD - 

2012 National ADAP Monitoring Project Annual Report - Module Two
3/20/2012 | Source: NASTAD - This module includes updated enrollment and utilization data and detailed information on ADAP coordination with Medicare Part D, ADAP coordination with Pre-existing Condition Insurance Plans (PCIPs) and ADAP coordination with the CMS Section 1115 Waiver process.

2012 National ADAP Monitoring Project Annual Report - Module Three
3/20/2012 | Source: NASTAD - This module highlights hepatitis treatments covered by ADAPs.

Slide Set: 2012 National ADAP Monitoring Project Annual Report - Module One
1/10/2012 | Source: NASTAD - This slide set includes detailed information related to ADAP budgets, client enrollment and utilization, client demographics, prescription distribution and payment methods, expenditures and prescriptions filled, insurance coordination, program eligibility, and program management and administration.

Press Release: 2012 National ADAP Monitoring Project Annual Report - Module One
1/10/2012 | Source: NASTAD - 

2012 National ADAP Monitoring Project Annual Report - Module One
1/10/2012 | Source: NASTAD - This module includes detailed information related to ADAP budgets, client enrollment and utilization, client demographics, prescription distribution and payment methods, expenditures and prescriptions filled, insurance coordination, program eligibility, and program management and administration.